Patient-specific dosimetry

DEVICE2 trials

Sponsors

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Conditions

Head and Neck CancerLymphoma

Unknown Phase

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma

CompletedNCT00416312

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsLymphoma

Start: 2006-07-31End: 2009-10-31Updated: 2018-08-27

Iodine I 131 in Treating Patients With Thyroid Cancer

TerminatedNCT00416949

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsHead and Neck Cancer

Start: 2006-04-30End: 2009-10-31Updated: 2018-07-18